Associate Prof. Huaisong Wang
(1) Cell membrane engineering for anticancer therapy;
(2) Metal-organic frameworks for nucleic acid detection;
(3) Transmembrane delivery of mRNA vaccines.
1. Research Projects
（1）National Natural Science Foundation, 32271453, 2023.1-2026.12, Project leader
（2）National Natural Science Foundation, 31870946, 2019.1-2022.12, Project leader
（3）National Natural Science Foundation, 31470916, 2015.1-2018.12, Project leader
（4）National Natural Science Foundation, 30900337, 2010.1-2012.12, Project leader
2. Academic Awards
Jiangsu Science and Technology Award, Third Prize (2022)
Jiangsu Innovation in Science and Technology, Life Science Group, First Prize (2022)
“333 High-level Talent Training Project” in Jiangsu Province (2016)
Outstanding Scientific Research Award of Colleges and Universities, First Prize of Natural Science Award (2012)
Outstanding Young Teachers of “Qinglan Project” in Jiangsu Province (2010)
New Century Outstanding Talents Support Plan (2010)
3. Research Positions
Editorial board member of Journal of China Pharmaceutical University
Editorial board member of Acta Pharmaceutica Sinica
Young editor board of Chinese Chemical Letters
Young editor board of Nano Research
Young editor board of Journal of Pharmaceutical Analysis
Committee Member of China Medical Biotechnology Association (Nanobiotechnology Committee)
Youth Committee Member of China Anti-Cancer Association (Nano Oncology Professional Committee)
Committee Member of Chinese Society of Biomaterials (Imaging Materials and Technology Committee)
1. Wang, J.; Wang, J.; Xu, J.; Hou, T.; Yin, L.; Chen, H.; Ma, Y.; Chen, W.; Wang, Z.; Hou, Y.; Ding, Y. Anchoring a xenogeneic antigen-guided immune activation system to tumor cell membranes for solid tumor treatment. Adv. Funct. Mater. 2022, 211149. (SCI IF=19.924)
2. Zhang, L.; Wang, W.; Ou, M.; Huang, X.; Ma, Y.; Tang, J.; Hou, T.; Zhang, S.; Yin, L.; Chen, H.; Hou, Y.; Ding, Y. NIR-II photothermal therapy for effective tumour eradication enhanced by heterogeneous nanorods with dual catalytic activities. Nano Res. 2022, 15, 4310–4319. (SCI IF=10.269)
3. Li, R.; Ma, Y.; Hong, J.; Ding, Y. Nanoengineered therapy aiming at the etiology of rheumatoid arthritis. Nano Today 2022, 42, 101367. (SCI IF=18.962)
4. Wang, W.; Zhang, X.; Huang, R.; Hirschbiegel, C.; Wang, H.; Ding, Y.; Rotello, V. M. In situ activation of therapeutics through bioorthogonal catalysis. Adv. Drug Delivery Rev. 2021, 176, 113893. (SCI IF=17.873)
5. Mugaka, B. P.; Zhang, S.; Li, R.; Ma, Y.; Wang, B.; Hong, J.; Hu, Y.; Ding, Y.; Xia, X. One-pot preparation of peptide-doped metal–amino acid framework for general encapsulation and targeted delivery. ACS Appl. Mater. Interfaces 2021, 13, 11195–11204. (SCI IF=10.383)
6. Chen, W.; Zhang, F.; Ju, Y.; Hong, J.; Ding, Y. Gold nanomaterial engineering for macrophage‐mediated inflammation and tumor treatment. Adv. Healthc. Mater. 2021, 10, 2000818. (SCI IF=11.092)
7. Liu, A.; Wang, H.; Hou, X.; Ma, Y.; Yang, G.; Hou, Y.; Ding, Y. Combinatory antitumor therapy by cascade targeting of a single drug. Acta Pharm. Sin. B 2020, 10, 667–679. (SCI IF=11.413)
8. Hu, Y.; Lv, T.; Ma, Y.; Xu, J.; Zhang, Y.; Hou, Y.; Huang, Z.; Ding, Y. Nanoscale coordination polymers for synergistic NO and chemodynamic therapy of liver cancer. Nano Lett. 2019, 19, 2731–2738. (SCI IF=12.080)
9. Ju, Y.; Zhang, H.; Yu, J.; Tong, S.; Tian, N.; Wang, Z.; Wang, X.; Su, X.; Chu, X.; Lin, J.; Ding, Y.; Li, G.; Sheng, F.; Hou, Y. Monodisperse Au–Fe2C janus nanoparticles: an attractive multifunctional material for triple-modal imaging-guided tumor photothermal therapy. ACS Nano 2017, 11, 9239-9248. (SCI IF=13.942)
10. Zhang, H.; Yang, Z.; Ju, Y.; Chu, X.; Ding, Y.; Huang, X.; Zhu, K.; Tang, T.; Su, X.; Hou, Y.; Galvanic displacement synthesis of monodisperse janus‐and satellite‐like plasmonic–magnetic Ag–Fe@Fe3O4 heterostructures with reduced cytotoxicity. Adv. Sci. 2018, 5, 1800271. (SCI IF=9.034)
Associate Prof. Huaisong Wang
